Olympus (Olympus) Change In Receivables : $-127 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Olympus Change In Receivables?

Olympus's change in receivables for the quarter that ended in Dec. 2023 was $8 Mil. It means Olympus's Accounts Receivable declined by $8 Mil from Sep. 2023 to Dec. 2023 .

Olympus's change in receivables for the fiscal year that ended in Mar. 2023 was $-202 Mil. It means Olympus's Accounts Receivable increased by $202 Mil from Mar. 2022 to Mar. 2023 .

Olympus's Accounts Receivable for the quarter that ended in Dec. 2023 was $1,148 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Olympus's Days Sales Outstanding for the three months ended in Dec. 2023 was 63.08.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Olympus's liquidation value for the three months ended in Dec. 2023 was $-859 Mil.

Olympus Change In Receivables Historical Data

The historical data trend for Olympus's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Change In Receivables Chart

Olympus Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

50.24

11.85

-89.40

-92.61

-202.10

Olympus Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-2.34	-223.44	106.31	-17.74	7.77

Olympus Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-127 Mil.

Olympus (OTCPK:OLYMY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Olympus's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1147.842	/	1660.422	*	91
=	63.08

2. In Ben Graham's calculation of liquidation value, Olympus's accounts receivable are only considered to be worth 75% of book value:

Olympus's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2620.858	-	4988.113	+	0.75 * 1147.842	+	0.5 * 1295.423
=	-859

Olympus Change In Receivables Related Terms

Thank you for viewing the detailed overview of Olympus's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Olympus (Olympus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

OCPNF:USA 7733:Japan OLY1:Germany

Address

Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914

Website

http://www.olympus.co.jp

Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.